Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
17.14B
Market cap17.14B
Price-Earnings ratio
23.00
Price-Earnings ratio23.00
Dividend yield
1.08%
Dividend yield1.08%
Average volume
2.05M
Average volume2.05M
High today
High today
Low today
Low today
Open price
$87.74
Open price$87.74
Volume
0.00
Volume0.00
52 Week high
$108.29
52 Week high$108.29
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

As of today, Zimmer Biomet(ZBH) shares are valued at $88.57. The company's market cap stands at 17.14B, with a P/E ratio of 23.00 and a dividend yield of 1.1%.

Zimmer Biomet(ZBH) stock opened on 2026-06-15 at $87.74. The price climbed to — and dipped to —.

The Zimmer Biomet(ZBH)'s current trading volume is 0, compared to an average daily volume of 2.05M.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $108.29 and a 52-week low of $79.12.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $108.29 and a 52-week low of $79.12.

ZBH News

Simply Wall St 2d
Zimmer Biomet Stock Valuation After Growing Adoption Of ROSA Robotics And Cementless Implants - simplywall.st

...

Zimmer Biomet Stock Valuation After Growing Adoption Of ROSA Robotics And Cementless Implants - simplywall.st
Simply Wall St 4d
Does Zimmer Biomet’s Expanding ROSA Platform Reframe Its Orthopedic Innovation Story For Investors?

Zimmer Biomet Holdings recently highlighted its musculoskeletal portfolio and ROSA robotic-assisted surgery platform at the Goldman Sachs 47th Annual Global Hea...

Does Zimmer Biomet’s Expanding ROSA Platform Reframe Its Orthopedic Innovation Story For Investors?
TipRanks 7d
Zimmer Biomet’s Sidus Stem-Free Shoulder Study Update: What Investors Should Know

Zimmer Biomet Holdings (ZBH) announced an update on their ongoing clinical study. The Sidus Stem-Free Shoulder post market clinical follow-up study from Zimmer...

Analyst ratings

66%

of 29 ratings
Buy
31%
Hold
65.5%
Sell
3.4%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.